Редактирование: BioViva (раздел)

== Controversy ==
The treatment as well as the [[self-experimentation]] is highly controversial. Because the necessary pre-clinical work to progress to human studies, the US [[Food and Drug Administration]] did not authorise Parrish's experiment, requiring her to travel for treatment.

Timothy Caulfield, professor in the Faculty of Law and the School of Public Health at the University of Alberta characterising BioViva's work as '[[Pseudo-science]]' and lacking scientific rigour. George M Martin, professor of pathology at the University of Washington had agreed to be an adviser to the company but resigned on hearing about the self-experiment.<ref name="guardian" />